Home » Procyon, Medicorp Enter Into an Agreement for PSP94-Based Test Kits
Procyon, Medicorp Enter Into an Agreement for PSP94-Based Test Kits
Procyon Biopharma has announced that it has entered into a licensing and distribution agreement with Medicorp granting the latter the exclusive worldwide rights to develop, manufacture and commercialize PSP94-based test kits for research purposes as well as the rights to sub-license for clinical diagnostic applications.
Canada NewsWire
(http://www.newswire.ca/en/releases/archive/March2005/02/c0298.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct